Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine model

被引:7
|
作者
Phan, Thuy [1 ]
Nguyen, Vu H. [2 ]
Su, Rui [3 ]
Li, Yangchan [3 ]
Qing, Ying [3 ]
Qin, Hanjun [4 ]
Cho, Hyejin [4 ]
Jiang, Lei [5 ]
Wu, Xiwei [4 ]
Chen, Jianjun [3 ]
Fakih, Marwan [6 ]
Diamond, Don J. [2 ]
Goel, Ajay [7 ]
Melstrom, Laleh G. [1 ]
机构
[1] City Hope Natl Med Ctr, Dept Surg, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Hematol, Duarte, CA USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Syst Biol, Monrovia, CA USA
[4] City Hope Natl Med Ctr, Beckman Res Inst, Integrat Genom Core, Duarte, CA USA
[5] City Hope Natl Med Ctr, Dept Mol & Cellular Endocrinol, Duarte, CA USA
[6] City Hope Natl Med Ctr, Dept Med Oncol, Duarte, CA USA
[7] City Hope Natl Med Ctr, Dept Mol Diagnost & Expt Therapeut, Monrovia, CA USA
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
colorectal cancer; FTO; FTO inhibitor; RNA-seq; signaling pathways; NUCLEAR-RNA; CELL-CYCLE; PHASE-II; EXPRESSION; N6-METHYLADENOSINE; PROGRESSION; DEMETHYLASE; MECHANISMS; BISANTRENE; RESISTANCE;
D O I
10.3389/fonc.2023.1087644
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionColorectal cancer (CRC) remains a significant cause of cancer related mortality. Fat mass and obesity-associated protein (FTO) is a m6A mRNA demethylase that plays an oncogenic role in various malignancies. In this study we evaluated the role of FTO in CRC tumorigenesis. MethodsCell proliferation assays were conducted in 6 CRC cell lines with the FTO inhibitor CS1 (50-3200 nM) (+/- 5-FU 5-80 mM) and after lentivirus mediated FTO knockdown. Cell cycle and apoptosis assays were conducted in HCT116 cells (24 h and 48 h, 290 nM CS1). Western blot and m6A dot plot assays were performed to assess CS1 inhibition of cell cycle proteins and FTO demethylase activity. Migration and invasion assays of shFTO cells and CS1 treated cells were performed. An in vivo heterotopic model of HCT116 cells treated with CS1 or with FTO knockdown cells was performed. RNA-seq was performed on shFTO cells to assess which molecular and metabolic pathways were impacted. RT-PCR was conducted on select genes down-regulated by FTO knockdown. ResultsWe found that the FTO inhibitor, CS1 suppressed CRC cell proliferation in 6 colorectal cancer cell lines and in the 5-Fluorouracil resistant cell line (HCT116-5FUR). CS1 induced cell cycle arrest in the G2/M phase by down regulation of CDC25C and promoted apoptosis of HCT116 cells. CS1 suppressed in vivo tumor growth in the HCT116 heterotopic model (p< 0.05). Lentivirus knockdown of FTO in HCT116 cells (shFTO) mitigated in vivo tumor proliferation and in vitro demethylase activity, cell growth, migration and invasion compared to shScr controls (p< 0.01). RNA-seq of shFTO cells compared to shScr demonstrated down-regulation of pathways related to oxidative phosphorylation, MYC and Akt/ mTOR signaling pathways. DiscussionFurther work exploring the targeted pathways will elucidate precise downstream mechanisms that can potentially translate these findings to clinical trials.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Targeting Fat Mass and Obesity-associated Protein Mitigates Human Colorectal Cancer Growth in vitro and in a Murine Model
    Phan, Thuy
    Nguyen, Vu H.
    Su, Rui
    Qin, Hanjun
    Wu, Xiwei
    Diamond, Don
    Goel, Ajay
    Chen, Jianjun
    Melstrom, Laleh
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 383 - 383
  • [2] FAT MASS AND OBESITY-ASSOCIATED PROTEIN EXPRESSION IN COLORECTAL CANCER AND ITS INFLUENCE ON THE BIOLOGICAL BEHAVIOUR OF COLORECTAL CANCER CELLS
    Wu, Huihui
    Wu, Yibo
    Zhang, Zhishan
    Chen, Qinglin
    Zheng, Tingjin
    Zhong, Hui
    POLISH JOURNAL OF PATHOLOGY, 2024, 75 (04) : 343 - 352
  • [3] Fat mass and obesity-associated protein promotes liver steatosis by targeting PPARα
    Wei, Xiaohui
    Zhang, Jielei
    Tang, Min
    Wang, Xuejiao
    Fan, Nengguang
    Peng, Yongde
    LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)
  • [4] Fat mass and obesity-associated protein promotes the tumorigenesis and development of liver cancer
    Ye, Ziqi
    Wang, Shibing
    Chen, Wanyuan
    Zhang, Xin
    Chen, Jie
    Jiang, Jinying
    Wang, Mingshan
    Zhang, Li
    Xuan, Zixue
    ONCOLOGY LETTERS, 2020, 20 (02) : 1409 - 1417
  • [5] The role of the fat mass and obesity-associated protein in the proliferation of pancreatic cancer cells
    Tang, Xiaodong
    Liu, Shuanghai
    Chen, Dawei
    Zhao, Zhenguo
    Zhou, Jiahua
    ONCOLOGY LETTERS, 2019, 17 (02) : 2473 - 2478
  • [6] Emerging Function of Fat Mass and Obesity-Associated Protein (Fto)
    Mueller, Timo D.
    Tschoep, Matthias H.
    Hofmann, Susanna
    PLOS GENETICS, 2013, 9 (01):
  • [7] The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells
    Relier, Sebastien
    Rivals, Eric
    David, Alexandre
    RNA BIOLOGY, 2022, 19 (01) : 132 - 142
  • [8] Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis
    Li, Liping
    Zang, Liqun
    Zhang, Feiran
    Chen, Junchen
    Shen, Hui
    Shu, Liqi
    Liang, Feng
    Feng, Chunyue
    Chen, Deng
    Tao, Huikang
    Xu, Tianlei
    Li, Ziyi
    Kang, Yunhee
    Wu, Hao
    Tang, Lichun
    Zhang, Pumin
    Jin, Peng
    Shu, Qiang
    Li, Xuekun
    HUMAN MOLECULAR GENETICS, 2017, 26 (13) : 2398 - 2411
  • [9] Targeting IL-23 for the interception of obesity-associated colorectal cancer
    Madka, Venkateshwar
    Chiliveru, Srikanth
    Panneerselvam, Janani
    Pathuri, Gopal
    Zhang, Yuting
    Stratton, Nicole
    Kumar, Nandini
    Sanghera, Dharambir K.
    Rao, Chinthalapally V.
    NEOPLASIA, 2023, 45
  • [10] The Fat Mass and Obesity-Associated (FTO) Gene is Associated with Intramuscular Fat Content and Growth Rate in the Pig
    Fan, Bin
    Du, Zhi-Qiang
    Rothschild, Max F.
    ANIMAL BIOTECHNOLOGY, 2009, 20 (02) : 58 - 70